| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 148, 1949-1956, Copyright © 1996 by American Society for Investigative Pathology
REGULAR ARTICLES |
K Kanazawa, S Kawashima, S Mikami, Y Miwa, K Hirata, M Suematsu, Y Hayashi, H Itoh and M Yokoyama
First Department of Internal Medicine, Kobe University School of Medicine, Kobe, Japan.
Atherosclerotic arteries are well known to exhibit impaired endothelium- dependent relaxation (EDR), but the exact mechanism of this impairment remains unclear. Recently, endothelial constitutive nitric oxide synthase (ECNOS), which generates nitric oxide and mediates EDR, was cloned, and ECNOS mRNA expression was reported to be modified by various cytokines, lipoproteins, and shear stress. To investigate the expression of ECNOS mRNA and protein in atherosclerotic arteries with impaired EDR, thoracic aortas isolated from Watanabe heritable hyperlipidemic (WHHL) rabbits were examined by using in situ hybridization and immunohistochemistry. Compared with thoracic aortas from Japanese White rabbits, WHHL aortas exhibited significantly impaired EDRs, although both in situ hybridization and immunohistochemistry exhibited enhanced expression of ECNOS mRNA and protein in WHHL aortas. There was no significant relationship between expression of ECNOS mRNA and protein of endothelial cells and age of the examined WHHL aortas. These data suggest that the mechanism of impaired EDR in atherosclerotic arteries is not due to the decrease in ECNOS mRNA and protein.
This article has been cited by other articles:
![]() |
E. R. Duncan, S. J. Walker, V. A. Ezzat, S. B. Wheatcroft, J.-M. Li, A. M. Shah, and M. T. Kearney Accelerated endothelial dysfunction in mild prediabetic insulin resistance: the early role of reactive oxygen species Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1311 - E1319. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Takaya, K.-i. Hirata, T. Yamashita, M. Shinohara, N. Sasaki, N. Inoue, T. Yada, M. Goto, A. Fukatsu, T. Hayashi, et al. A Specific Role for eNOS-Derived Reactive Oxygen Species in Atherosclerosis Progression Arterioscler. Thromb. Vasc. Biol., July 1, 2007; 27(7): 1632 - 1637. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Cai Hydrogen peroxide regulation of endothelial function: Origins, mechanisms, and consequences Cardiovasc Res, October 1, 2005; 68(1): 26 - 36. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Laude, H. Cai, B. Fink, N. Hoch, D. S. Weber, L. McCann, G. Kojda, T. Fukai, H. H. H. W. Schmidt, S. Dikalov, et al. Hemodynamic and biochemical adaptations to vascular smooth muscle overexpression of p22phox in mice Am J Physiol Heart Circ Physiol, January 1, 2005; 288(1): H7 - H12. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kawashima and M. Yokoyama Dysfunction of Endothelial Nitric Oxide Synthase and Atherosclerosis Arterioscler. Thromb. Vasc. Biol., June 1, 2004; 24(6): 998 - 1005. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ejiri, N. Inoue, T. Tsukube, T. Munezane, Y. Hino, S. Kobayashi, K.-i. Hirata, S. Kawashima, S. Imajoh-Ohmi, Y. Hayashi, et al. Oxidative stress in the pathogenesis of thoracic aortic aneurysm: Protective role of statin and angiotensin II type 1 receptor blocker Cardiovasc Res, October 1, 2003; 59(4): 988 - 996. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zulli, R. E. Widdop, D. L. Hare, B. F. Buxton, and M. J. Black High Methionine and Cholesterol Diet Abolishes Endothelial Relaxation Arterioscler. Thromb. Vasc. Biol., August 1, 2003; 23(8): 1358 - 1363. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Okuda, N. Inoue, H. Azumi, T. Seno, Y. Sumi, K.-i. Hirata, S. Kawashima, Y. Hayashi, H. Itoh, J. Yodoi, et al. Expression of Glutaredoxin in Human Coronary Arteries: Its Potential Role in Antioxidant Protection Against Atherosclerosis Arterioscler. Thromb. Vasc. Biol., September 1, 2001; 21(9): 1483 - 1487. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. V. d'Uscio, T. A. Baker, C. B. Mantilla, L. Smith, D. Weiler, G. C. Sieck, and Z. S. Katusic Mechanism of Endothelial Dysfunction in Apolipoprotein E-Deficient Mice Arterioscler. Thromb. Vasc. Biol., June 1, 2001; 21(6): 1017 - 1022. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kawashima, T. Yamashita, M. Ozaki, Y. Ohashi, H. Azumi, N. Inoue, K.-i. Hirata, Y. Hayashi, H. Itoh, and M. Yokoyama Endothelial NO Synthase Overexpression Inhibits Lesion Formation in Mouse Model of Vascular Remodeling Arterioscler. Thromb. Vasc. Biol., February 1, 2001; 21(2): 201 - 207. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Liuba, P. Karnani, E. Pesonen, I. Paakkari, A. Forslid, L. Johansson, K. Persson, T. Wadstrom, and R. Laurini Endothelial Dysfunction After Repeated Chlamydia pneumoniae Infection in Apolipoprotein E-Knockout Mice Circulation, August 29, 2000; 102(9): 1039 - 1044. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Landmesser, R. Merten, S. Spiekermann, K. Buttner, H. Drexler, and B. Hornig Vascular Extracellular Superoxide Dismutase Activity in Patients With Coronary Artery Disease : Relation to Endothelium-Dependent Vasodilation Circulation, May 16, 2000; 101(19): 2264 - 2270. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. R. Drummond, H. Cai, M. E. Davis, S. Ramasamy, and D. G. Harrison Transcriptional and Posttranscriptional Regulation of Endothelial Nitric Oxide Synthase Expression by Hydrogen Peroxide Circ. Res., February 18, 2000; 86(3): 347 - 354. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schwemmer, O. Sommer, R. Koeckerbauer, and E. Bassenge Cardiovascular Dysfunction in Hypercholesterolemia Associated With Enhanced Formation of ATI-Receptor and of Eicosanoids Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2000; 5(1): 59 - 68. [Abstract] [PDF] |
||||
![]() |
H. Azumi, N. Inoue, S. Takeshita, Y. Rikitake, S. Kawashima, Y. Hayashi, H. Itoh, and M. Yokoyama Expression of NADH/NADPH Oxidase p22phox in Human Coronary Arteries Circulation, October 5, 1999; 100(14): 1494 - 1498. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Papapetropoulos, R. D. Rudic, and W. C Sessa Molecular control of nitric oxide synthases in the cardiovascular system Cardiovasc Res, August 15, 1999; 43(3): 509 - 520. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Linz, P. Wohlfart, B. A Scholkens, T. Malinski, and G. Wiemer Interactions among ACE, kinins and NO Cardiovasc Res, August 15, 1999; 43(3): 549 - 561. [Full Text] [PDF] |
||||
![]() |
H. Yamawaki, K. Sato, M. Hori, H. Ozaki, S.-I. Nakamura, H. Nakayama, K. Doi, and H. Karaki Impairment of EDR by a long-term PDGF treatment in organ-cultured rabbit mesenteric artery Am J Physiol Heart Circ Physiol, July 1, 1999; 277(1): H318 - H323. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ooboshi, K. Toyoda, F. M. Faraci, M. G. Lang, and D. D. Heistad Improvement of Relaxation in an Atherosclerotic Artery by Gene Transfer of Endothelial Nitric Oxide Synthase Arterioscler. Thromb. Vasc. Biol., November 1, 1998; 18(11): 1752 - 1758. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Förstermann, J.-p. Boissel, and H. Kleinert Expressional control of the `constitutive' isoforms of nitric oxide synthase (NOS I and NOS III) FASEB J, July 1, 1998; 12(10): 773 - 790. [Abstract] [Full Text] |
||||
![]() |
B. S. Oemar, M. R. Tschudi, N. Godoy, V. Brovkovich, T. Malinski, and T. F. Luscher Reduced Endothelial Nitric Oxide Synthase Expression and Production in Human Atherosclerosis Circulation, June 30, 1998; 97(25): 2494 - 2498. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. FARACI and D. D. HEISTAD Regulation of the Cerebral Circulation: Role of Endothelium and Potassium Channels Physiol Rev, January 1, 1998; 78(1): 53 - 97. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bonthu, D. D. Heistad, D. A. Chappell, K. G. Lamping, and F. M. Faraci Atherosclerosis, Vascular Remodeling, and Impairment of Endothelium-Dependent Relaxation in Genetically Altered Hyperlipidemic Mice Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2333 - 2340. [Abstract] [Full Text] |
||||
![]() |
S. Mikami, S. Kawashima, K. Kanazawa, K.-i. Hirata, H. Hotta, Y. Hayashi, H. Itoh, and M. Yokoyama Low-Dose N{omega}-Nitro-L-Arginine Methyl Ester Treatment Improves Survival Rate and Decreases Myocardial Injury in a Murine Model of Viral Myocarditis Induced by Coxsackievirus B3 Circ. Res., October 19, 1997; 81(4): 504 - 511. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |